M. Hew

发表

High body mass index and pre-existing autoimmune disease are associated with an increased risk of immune-related adverse events in cancer patients treated with PD-(L)1 inhibitors across different solid tumors

S. Teerenstra, L. Rodwell, B. Fabriek, 2021, ESMO open.

Vimentin over-expression and carbonic anhydrase IX under-expression are independent predictors of recurrence, specific and overall survival in non-metastatic clear-cell renal carcinoma: a validation study

F. Algaba, S. Horenblas, P. Zondervan, 2016, World Journal of Urology.

ELECTROCARDIOGRAPHIC MONITORING OF TREATMENT RESPONSE IN PULMONARY ARTERIAL HYPERTENSION PATIENTS

J., O. Kamp, É., 2008 .

Are there parameters that predict a nondiagnostic biopsy outcome taken during laparoscopic-assisted cryoablation of small renal tumors?

J. J. de la Rosette, H. Wijkstra, M. P. Laguna, 2011, Journal of endourology.

Critical appraisal of the PADUA classification and assessment of the R.E.N.A.L. nephrometry score in patients undergoing partial nephrectomy.

S. Horenblas, A. Bex, J. Rosette, 2011, The Journal of urology.

Age and gender related differences in renal cell carcinoma in a European cohort.

J. J. de la Rosette, M. P. Laguna, R. Zonneveld, 2012, The Journal of urology.

The 1‐year decline in estimated glomerular filtration rate (eGFR) after radical nephrectomy in patients with renal masses and matched living kidney donors is the same

F. Bemelman, J. Rosette, M. P. Laguna, 2014, BJU international.

ECG monitoring of treatment response in pulmonary arterial hypertension patients.

O. Kamp, J. Twisk, M. Schalij, 2008, Chest.

UvA-DARE ( Digital Academic Repository ) Reflections on the current knowledge of epidemiology , treatment and prognosis for renal cell carcinoma

S. Guven, P. Zondervan, J. Rosette, 2016 .

Prognostic models and factors for patients with renal-cell carcinoma: a survey on their use among urologists.

J. J. de la Rosette, S. Guven, P. Zondervan, 2013, Journal of endourology.